14 reports of this reaction
2.1% of all BENZOCAINE AND MENTHOL reports
#7 most reported adverse reaction
SEPSIS is the #7 most commonly reported adverse reaction for BENZOCAINE AND MENTHOL, manufactured by RB Health (US) LLC. There are 14 FDA adverse event reports linking BENZOCAINE AND MENTHOL to SEPSIS. This represents approximately 2.1% of all 672 adverse event reports for this drug.
Patients taking BENZOCAINE AND MENTHOL who experience sepsis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEPSIS is a less commonly reported adverse event for BENZOCAINE AND MENTHOL, but still significant enough to appear in the safety profile.
In addition to sepsis, the following adverse reactions have been reported for BENZOCAINE AND MENTHOL:
The following drugs have also been linked to sepsis in FDA adverse event reports:
SEPSIS has been reported as an adverse event in 14 FDA reports for BENZOCAINE AND MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEPSIS accounts for approximately 2.1% of all adverse event reports for BENZOCAINE AND MENTHOL, making it a notable side effect.
If you experience sepsis while taking BENZOCAINE AND MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.